StreetAlpha.app
Home › Stocks › HNGE

Hinge Health, Inc. (HNGE)

Healthcare
$105.78
▼ −2.15%
LAST CLOSE · NOV 20

Hinge Health offers AI-based remote care for joint and muscle pain to employers, health plans and government insurance programs. It last closed at $105.78 on Nov 20, down 2.15% on the day. The next earnings report for HNGE is expected around Tue, Feb 9, 2027, after the close. For the quarter ended Sep 2026, HNGE reported EPS of $0.66 on revenue of $235.0M, with revenue up 52.4% from a year ago. Over its last 6 reports the stock moved an average of 11.8% the session after earnings. Over the last 12 months HNGE insiders bought $0 of stock on the open market and sold $542.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is HNGE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HNGE.

Key Stats

Last 12 months
Results
Revenue
$800.8M
+49.9% vs a year ago
Net income
$168.3M
21.0% margin
EPS (diluted)
$3.69
Free cash flow
$322.0M
40.2% margin
Balance sheet
Cash & equivalents
$211.6M
At Sep 30
Shareholder equity
$299.4M
Buybacks
$222.4M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2023: $292.7M$292.7MFY2023FY2024: $390.4M$390.4MFY2024FY2025: $587.9M$587.9MFY2025

From HNGE's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Feb 9
Estimated date · After the close
Reported EPS
$0.66
Quarter ended Sep 2026
Year ago EPS
-$0.02
Same quarter last year
Revenue
$235.0M
+52.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $2.01Dec '24Mar 2025: $1.31Mar '25Jun 2025: -$13.10Jun '25Sep 2025: -$0.02Sep '25Dec 2025: $2.11Dec '25Mar 2026: $0.41Mar '26Jun 2026: $0.52Jun '26Sep 2026: $0.66Sep '26Latest $0.66
Revenue by quarter
Dec 2024: $117.3MDec '24Mar 2025: $123.8MMar '25Jun 2025: $139.1MJun '25Sep 2025: $154.2MSep '25Dec 2025: $170.7MDec '25Mar 2026: $182.3MMar '26Jun 2026: $212.8MJun '26Sep 2026: $235.0MSep '26Latest $235.0M
How HNGE moved after its last 6 reports
Average move the session after a report ±11.8%
Nov 2, 2026After the close+1.2%
Aug 4, 2026After the close+1.7%
May 5, 2026After the close+10.2%
Feb 10, 2026After the close+17.3%
Nov 4, 2025After the close−15.1%
Aug 5, 2025After the close+25.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on HNGEStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HNGE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HNGE

Technical Analysis

HNGE · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 10% below its 20 day and 0% below its 50 day average. It is 31% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $102.87, and the nearest resistance the Pivot at $106.03.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 5.6%/day
Key levels
$126.4052 week high+19.5%
$116.2320 day average+9.9%
$108.93Pivot R1+3.0%
$107.00Swing high (Oct 13)+1.2%
$106.0750 day average+0.3%
$106.03Pivot+0.2%
$105.78Last close
$102.87Pivot S1−2.8%
$97.44Swing low (Oct 16)−7.9%
$96.05100 day average−9.2%
$72.93200 day average−31.1%
$30.0852 week low−71.6%
Indicators
RSI (14)41.36Middle of its rangeNeutral
MACD1.57Below its signal lineBearish
Stochastic12.4Near the bottom of its rangeOversold
ADX (14)25.4Trending down
Williams %R-88.6Oversold below −80, overbought above −20Oversold
CCI (20)-226.9Oversold below −100, overbought above 100Oversold
Rate of change−8.6%Change over 10 sessionsBearish
ATR (14)$5.95Typical daily range, 5.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for HNGE

What happened before

See how HNGE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for HNGEHow many large options trades hit HNGE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

HNGE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲251 buying vs 125 selling
  • ▲Shares held by funds +15.1%
  • ▲Funds holding +88
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding368280+31.4%
In funds' top 102018+11.1%
Held by funds–––
New / increased122 / 129103 / 93+28.1%
Reduced / sold out92 / 3365 / 27+35.9%
Put/call ratio0.240.42−42.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HNGE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

HNGE Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$542.6M46 sales · 7 insiders
85% of the selling was under pre-arranged trading plans.
2025-12 sold $88.3M2026-01 sold $7.7M2026-02 sold $7.9M2026-03 sold $8.7M2026-04 sold $3.4M2026-05 sold $17.0M2026-06 sold $236.7M2026-07 sold $45.5M2026-08 sold $3.0M2026-09 sold $66.7M2026-10 sold $26.0M2026-11 sold $28.8MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 11Gabriel M.I. MecklenburgDirectorSale plan200,000$122.41$24.5M
Nov 10James BudgeCFOSale plan35,907$121.62$4.4M
Oct 12James BudgeCFOSale plan47,720$103.13$4.9M
Oct 12Gabriel M.I. MecklenburgDirectorSale plan200,000$103.13$20.6M
Oct 6Daniel Antonio PerezCEO & Co-FounderSale plan4,100$100.20$411K
Sep 21James PursleyPresidentSale plan33,000$94.14$3.1M
Every insider buy and sale for HNGE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See HNGE insider trades →

From SEC Form 4 filings by HNGE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HNGE is in one of them and how their past HNGE trades turned out.

HNGE in the AI portfolios
Loading…

HNGE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HNGE in an article yet. Here's the latest on the wider market.

HNGE in the news

About Hinge Health

Hinge Health is a software company based in San Francisco, California, that provides remote care for joint and muscle pain. Its platform combines AI motion tracking, a nerve stimulation wearable, and a care team of licensed physical therapists, physicians, and health coaches. Its customers include employers that fund their own health benefits, health plans, pharmacy benefit managers, and government insurance programs.

Headquarters
San Francisco, CA